NZ209635A - Pharmaceutical composition containing extract from microorganism and detoxified endotoxin - Google Patents
Pharmaceutical composition containing extract from microorganism and detoxified endotoxinInfo
- Publication number
- NZ209635A NZ209635A NZ209635A NZ20963584A NZ209635A NZ 209635 A NZ209635 A NZ 209635A NZ 209635 A NZ209635 A NZ 209635A NZ 20963584 A NZ20963584 A NZ 20963584A NZ 209635 A NZ209635 A NZ 209635A
- Authority
- NZ
- New Zealand
- Prior art keywords
- microorganism
- pharmaceutical composition
- composition containing
- detoxified endotoxin
- containing extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/535,037 US4663306A (en) | 1983-09-23 | 1983-09-23 | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ209635A true NZ209635A (en) | 1989-01-27 |
Family
ID=24132594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ209635A NZ209635A (en) | 1983-09-23 | 1984-09-21 | Pharmaceutical composition containing extract from microorganism and detoxified endotoxin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4663306A (enExample) |
| JP (1) | JPS60120817A (enExample) |
| KR (1) | KR870000843B1 (enExample) |
| AT (1) | AT385659B (enExample) |
| AU (1) | AU566234B2 (enExample) |
| BE (1) | BE900650A (enExample) |
| CA (1) | CA1244765A (enExample) |
| CH (1) | CH664897A5 (enExample) |
| DE (1) | DE3434766C2 (enExample) |
| DK (1) | DK446684A (enExample) |
| ES (1) | ES8608872A1 (enExample) |
| FI (1) | FI843716L (enExample) |
| FR (1) | FR2552326B1 (enExample) |
| GB (1) | GB2149301B (enExample) |
| HU (1) | HU192585B (enExample) |
| IL (1) | IL73034A (enExample) |
| IN (1) | IN157240B (enExample) |
| IT (1) | IT1179444B (enExample) |
| NL (1) | NL8402902A (enExample) |
| NO (1) | NO843776L (enExample) |
| NZ (1) | NZ209635A (enExample) |
| SE (1) | SE8404707L (enExample) |
| ZA (1) | ZA847405B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844894A (en) * | 1984-07-12 | 1989-07-04 | Ribi Immunochem Research Inc. | Method of inhibiting the onset of septicemia and endotoxemia |
| US4806352A (en) * | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
| US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US4929604A (en) * | 1986-05-28 | 1990-05-29 | Board Of Regents, The University Of Texas System | Lipopolysaccharides of reduced toxicity and the production thereof |
| WO1995005837A1 (en) * | 1993-08-27 | 1995-03-02 | Vetrepharm, Inc. | Composition and method for stimulation of reproductive performance |
| US6090385A (en) * | 1993-12-10 | 2000-07-18 | Maes; Hubert | Method of treating cancer |
| BE1007823A3 (fr) * | 1993-12-10 | 1995-10-31 | Anda Biolog Sa | Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer. |
| US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| DE19710255A1 (de) * | 1997-03-13 | 1998-09-17 | Henkel Ecolab Gmbh & Co Ohg | Verwendung einer Lösung zur Desaktivierung von Endotoxinen |
| HU227921B1 (hu) | 1997-08-05 | 2012-06-28 | Bioniche Life Sciences Inc | Készítmény és eljárás sejtproliferáció és sejtpusztulás szabályozására |
| US6019985A (en) * | 1998-02-27 | 2000-02-01 | Munova Corporation | Immunostimulation methods for providing disease protection in poultry |
| KR100628007B1 (ko) | 1998-07-16 | 2006-09-26 | 이치로 아즈마 | 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제 |
| AU785212B2 (en) * | 1999-12-13 | 2006-11-09 | Bioniche Life Sciences Inc. | Therapeutically useful synthetic oligonucleotides |
| DK1250152T3 (da) * | 1999-12-28 | 2013-08-26 | Bioniche Urology Ip Inc | Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer |
| JP5106736B2 (ja) * | 2000-07-11 | 2012-12-26 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト | 臓器線維形成に対するパラポックスウイルスｏｖｉｓ株の使用 |
| JP4176021B2 (ja) * | 2002-03-05 | 2008-11-05 | セルメディシン株式会社 | 固体化組織免疫アジュバント |
| WO2004012751A1 (ja) * | 2002-08-02 | 2004-02-12 | Sumitomo Pharmaceuticals Company, Limited | 細菌細胞壁骨格成分製剤 |
| FR2848223B1 (fr) * | 2002-12-09 | 2005-02-25 | Centre Nat Rech Scient | Nouveau procede d'isolement des endotoxines. |
| AU2003261624A1 (en) * | 2003-09-05 | 2005-03-29 | Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. | A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion |
| WO2005102369A1 (ja) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | 細菌細胞壁骨格成分を含有する製剤 |
| HK1214510A1 (zh) | 2013-04-18 | 2016-07-29 | Immune Design Corp. | 用於癌症治疗的gla单一疗法 |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| PL3158054T3 (pl) | 2014-06-17 | 2025-07-21 | Crown Laboratories, Inc. | Bakterie zmodyfikowane genetycznie i sposoby modyfikacji genetycznej bakterii |
| US11504404B2 (en) | 2016-02-24 | 2022-11-22 | Crown Laboratories, Inc. | Skin probiotic formulation |
| EP3668957A4 (en) * | 2017-08-17 | 2021-06-02 | University of Delaware | Furan based compositions and methods of making thereof |
| JP2023533202A (ja) | 2020-06-23 | 2023-08-02 | クラウン ラボラトリーズ，インコーポレイテッド | プロバイオティクス皮膚製剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7308450A (enExample) * | 1972-06-20 | 1973-12-27 | ||
| FR2269962B1 (enExample) * | 1974-05-06 | 1978-02-03 | Anvar | |
| JPS58874B2 (ja) * | 1979-08-30 | 1983-01-08 | 株式会社 目黒研究所 | 糖蛋白ｗｅｎａｃ及びその製造法 |
| US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| CA1206416A (en) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Pyridine soluble extract of a microorganism |
| CA1209504A (en) * | 1982-06-30 | 1986-08-12 | John L. Cantrell | Pyridine soluble extract of a microorganism |
| CA1206415A (en) * | 1982-06-30 | 1986-06-24 | John L. Cantrell | Pyridine soluble extract of a microorganism |
-
1983
- 1983-09-23 US US06/535,037 patent/US4663306A/en not_active Expired - Lifetime
-
1984
- 1984-09-19 DK DK446684A patent/DK446684A/da not_active Application Discontinuation
- 1984-09-20 ZA ZA847405A patent/ZA847405B/xx unknown
- 1984-09-20 NO NO843776A patent/NO843776L/no unknown
- 1984-09-20 SE SE8404707A patent/SE8404707L/xx not_active Application Discontinuation
- 1984-09-21 DE DE3434766A patent/DE3434766C2/de not_active Expired
- 1984-09-21 FR FR8414533A patent/FR2552326B1/fr not_active Expired
- 1984-09-21 ES ES536167A patent/ES8608872A1/es not_active Expired
- 1984-09-21 HU HU843585A patent/HU192585B/hu unknown
- 1984-09-21 NL NL8402902A patent/NL8402902A/nl not_active Application Discontinuation
- 1984-09-21 FI FI843716A patent/FI843716L/fi not_active Application Discontinuation
- 1984-09-21 GB GB08423993A patent/GB2149301B/en not_active Expired
- 1984-09-21 NZ NZ209635A patent/NZ209635A/xx unknown
- 1984-09-21 CA CA000463800A patent/CA1244765A/en not_active Expired
- 1984-09-21 CH CH4544/84A patent/CH664897A5/de not_active IP Right Cessation
- 1984-09-21 AU AU33400/84A patent/AU566234B2/en not_active Ceased
- 1984-09-21 BE BE0/213703A patent/BE900650A/fr not_active IP Right Cessation
- 1984-09-22 KR KR1019840005821A patent/KR870000843B1/ko not_active Expired
- 1984-09-23 IL IL73034A patent/IL73034A/xx unknown
- 1984-09-24 AT AT0302384A patent/AT385659B/de not_active IP Right Cessation
- 1984-09-24 IT IT48894/84A patent/IT1179444B/it active
- 1984-09-25 IN IN677/CAL/84A patent/IN157240B/en unknown
- 1984-09-25 JP JP59198764A patent/JPS60120817A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ209635A (en) | Pharmaceutical composition containing extract from microorganism and detoxified endotoxin | |
| GB2210557B (en) | Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant. | |
| IT1164626B (it) | Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati | |
| JPS5791915A (en) | Novel lipid composition useful for dietetics, resuscitation and treatment | |
| GR76073B (enExample) | ||
| DE3370482D1 (en) | Substituted 8-phenylxanthines | |
| HU9301089D0 (en) | Preparative containing antigenes for treating autoimmunic diseases | |
| GB8426735D0 (en) | Composition for treating alcohol and drug addicts | |
| AU551719B2 (en) | Anthralin compositions for treatment of skin diseases | |
| AU555073B2 (en) | Post expansion heat treatment of tobacco | |
| JPS57169482A (en) | Imidazopyrimidine derivative and application to medicine | |
| FI880954A7 (fi) | Seos ja menetelmä immunologista kastrointia varten. | |
| FR2550945B1 (fr) | Compositions d'endotoxines purifiees et leur application pharmacologique | |
| AU8770282A (en) | Composition for the treatment of atherosclerosis | |
| AU1980183A (en) | Compositions for inducing immunosuppression or immunoregulation of the immune response to an antigen | |
| IT8323139A0 (it) | Caviglia per l'assemblaggio di parti di mobili. | |
| GB2144129B (en) | Antigens as immunostimulant adjuvants | |
| PT85284A (fr) | Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions | |
| JPS57167477A (en) | Treatment of coal combustion ash | |
| IL63338A0 (en) | Vaccine against bacterial diseases and its preparation | |
| IT1174140B (it) | Metodo per l' estrazione di fenilalanina da brodi di bioconversione | |
| PL266503A1 (en) | Method of more rationalized utilization of smoke from bee-keeper's smokers | |
| ES523253A0 (es) | "metodo de preparar antigenos glicorrelacionados". | |
| IT8422933A1 (it) | Procedimento per l'estrazione di essenza di bergamotto |